VERO BEACH, Fla., Feb. 19, 2025 /PRNewswire/ -- QOL Medical, LLC, a ground-breaking rare disease pharmaceutical company, has announced that it will no longer sponsor the 13 C-sucrose breath test ...
This new coordinated research project (CRP) seeks to merge lessons and results from two on-going IAEA CRPs to provide information on the intersection between environmental enteric dysfunction (EED) ...
Congenital Sucrase-Isomaltase Deficiency (CSID) is largely a clinical diagnosis that requires a thorough review of the patient's medical history. While there are several tests available to aid in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback